Retail hits rock bottom, GSK-Pfizer combo, Taking Stock on tech valuations & more

Retailers are enduring what is shaping up to be the worst festive trading period since the 2008 financial crash – and there's already one major casualty. Does what’s happened at Asos – and the subsequent market sell-off of other retail stocks – indicate the end of the e-commerce boom? Click here to read a gloomy News Spotlight from Harriet Russell.

Sticking with the retail theme, Mark Robinson says the profit warning from Asos shows that ‘tech’ valuations count for nothing in the face of wider consumer trends. Click here to read the latest Taking Stock.

And GlaxoSmithKline is to establish a new consumer health joint venture with US-based Pfizer. As Harriet Russell puts it, GSK knows its focus is split, and plans to do something about it. Click here to read our tip update

In the latest magazine, the companies team reported on existing risks in their sectors, including the impact Brexit could have on pharma. Read the feature here.

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now